Trial Profile
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs TRN 157 (Primary) ; Tiotropium bromide
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Theron Pharmaceuticals
- 17 Oct 2016 Status changed from recruiting to completed.
- 13 Mar 2015 New trial record